Innovent Biopharmaceutical Technology
As of the edition of 20 October 2026, Innovent Biopharmaceutical Technology runs 7 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 7 |
| Total | 7 |
Where its trials are
- Cancer: 2 trials led
- Digestive system: 2 trials led
- Skin and connective tissue: 2 trials led